Testing times for diagnostics firm UGenix as Covid demand drops
The medical technology company is looking to list in Hong Kong after a windfall from Covid testing, but its other screening services are not yet lucrative Key Takeaways: Covid tests…
Recent Articles
RELATED ARTICLES
-
New Horizon Health finds formula for profits ahead of schedule
6606.HK
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
Burning Rock narrows losses with drug research as new driver
BNR.US
- Medical imaging group Rimag sets growth focus with IPO
-
Rebounding Perfect Medical finds beauty safe haven in Hong Kong
1830.HK
- Malo Medical pitches IPO to help fill China’s dentistry gap
Discover hidden China stock gems in our weekly newsletter